NuVasive Gestion
Gestion contrôle des critères 3/4
Le PDG NuVasive est Chris Barry, nommé en Nov2018, a un mandat de 4.83 ans. La rémunération annuelle totale est $ 8.08M, composée du salaire de 11.1% et des bonus 88.9%, y compris les actions et options de la société. détient directement 0.14% des actions de la société, d'une valeur de $ 2.90M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.7 ans et 5.6 ans.
Informations clés
Chris Barry
Directeur général
US$8.1m
Rémunération totale
| Pourcentage du salaire du PDG | 11.1% |
| Durée du mandat du directeur général | 4.8yrs |
| Propriété du PDG | 0.1% |
| Durée moyenne d'occupation des postes de direction | 3.7yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 5.6yrs |
Mises à jour récentes de la gestion
Recent updates
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Apr 18
What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?
Jan 24NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price
Dec 31Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Dec 05These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well
Nov 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Sep 22Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Sep 01NuVasive Likely Undervalued, But It's Hard To Find Catalysts
Aug 17Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Aug 11NuVasive Non-GAAP EPS of $0.47 misses by $0.09, revenue of $310.5M beats by $4.12M
Aug 03NuVasive: Industry Tailwinds More Than Fairly Priced
Jun 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jun 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
May 11NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Apr 20At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?
Mar 30NuVasive's Turnaround Story Needs A Boost From Better Results
Mar 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
Dec 28Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?
Dec 02NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Nov 11NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate
Oct 21Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital
Sep 29At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?
Aug 18NuVasive Still Getting No Love With COVID-19 And Competitive Worries
Aug 12Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Jul 27Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?
Jun 17Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital
May 30Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All
May 12Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Mar 30Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?
Mar 09Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares
Feb 16
A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jan 26NuVasive stock gains on study results of its X360 surgery approach
Jan 06What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Jan 05Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | US$28m |
| Mar 31 2023 | n/a | n/a | US$20m |
| Dec 31 2022 | US$8m | US$897k | US$40m |
| Sep 30 2022 | n/a | n/a | -US$20m |
| Jun 30 2022 | n/a | n/a | -US$40m |
| Mar 31 2022 | n/a | n/a | -US$37m |
| Dec 31 2021 | US$8m | US$875k | -US$64m |
| Sep 30 2021 | n/a | n/a | -US$26m |
| Jun 30 2021 | n/a | n/a | US$2m |
| Mar 31 2021 | n/a | n/a | -US$50m |
| Dec 31 2020 | US$5m | US$735k | -US$37m |
| Sep 30 2020 | n/a | n/a | -US$9m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | n/a | n/a | US$61m |
| Dec 31 2019 | US$5m | US$800k | US$65m |
| Sep 30 2019 | n/a | n/a | US$48m |
| Jun 30 2019 | n/a | n/a | US$52m |
| Mar 31 2019 | n/a | n/a | US$49m |
| Dec 31 2018 | US$5m | US$92k | US$12m |
Rémunération vs marché: La rémunération totale de Chris ($USD 8.08M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 5.34M ).
Rémunération et revenus: La rémunération de Chris a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Chris Barry (50 yo)
4.8yrs
Titularisation
US$8,077,095
Compensation
Mr. J. Christopher Barry, also known as Chris, serves as Chief Executive Officer and Director of NuVasive, Inc., since November 5, 2018. Mr. Barry served commercial and leadership roles at Covidien. He has...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Director | 4.8yrs | US$8.08m | 0.14% $ 2.9m | |
| Principal Accounting Officer | 3.7yrs | US$2.97m | 0.020% $ 418.2k | |
| Senior Vice President of Global Operations | 3.7yrs | US$1.48m | 0.017% $ 355.5k | |
| Senior VP | 5.3yrs | US$1.54m | 0.042% $ 869.2k | |
| Senior Vice President of People & Culture | less than a year | US$1.03m | 0.0059% $ 123.8k | |
| Senior VP & Chief Technology Officer | 2yrs | pas de données | pas de données | |
| Vice President of Investor Relations | no data | pas de données | pas de données | |
| Senior Vice President of Strategy & Corporate Development | 3.8yrs | pas de données | pas de données | |
| Vice President & Head of Global Commercial Finance | 5.3yrs | pas de données | pas de données | |
| Senior Vice President of Information Technology | 1.7yrs | pas de données | pas de données | |
| Vice President | 5.3yrs | pas de données | pas de données |
3.7yrs
Durée moyenne de l'emploi
48yo
Âge moyen
Gestion expérimentée: L'équipe de direction de NUVA est considérée comme expérimentée (ancienneté moyenne 3.7 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Director | 4.8yrs | US$8.08m | 0.14% $ 2.9m | |
| Independent Director | 5.6yrs | US$260.01k | 0% $ 0 | |
| Independent Director | 7.6yrs | US$260.01k | 0% $ 0 | |
| Independent Director | 8.3yrs | US$280.01k | 0.0038% $ 79.4k | |
| Independent Director | 4.9yrs | US$260.01k | 0.0026% $ 54.0k | |
| Independent Chair | 8.2yrs | US$405.01k | 0% $ 0 | |
| Independent Director | 9.3yrs | US$270.01k | 0.0059% $ 123.0k | |
| Independent Director | 2.6yrs | US$260.01k | 0.0071% $ 148.7k | |
| Independent Director | 2.1yrs | US$260.01k | 0% $ 0 |
5.6yrs
Durée moyenne de l'emploi
59yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de NUVA sont considérés comme expérimentés (ancienneté moyenne 5.6 ans).